A PYMNTS Company

US: Bullish investor makes bold $50B move to acquire Botox maker

By  |  April 22, 2014

Known as one of the most headstrong investors on Wall Street, activist investor William A. Ackman announced a joint bid with pharmaceutical company Valeant to acquire Botox maker Allergan in a $50 billion deal, say reports.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    If successful, the transaction could usher in a new era for how acquisitions are made, reports say. The proposed deal is the first of its kind.

    Ackman has slowly been acquiring Allergan shares through his Pershing Square Capital Management. Canada-based Valeant has reportedly agreed to pursue a takeover and contributed $76 million to Pershing Square’s PS Fund 1, according to regulatory filings.

    The joint pursuit of an investor and corporation could signal change in how the two groups work together, reports say, but also raises some concern over conflicts of interest.

    Full Content: DealBook

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.